Mirjam K de Vries, Irene E van der Horst-Bruinsma, Gerrit Jan Wolbink. Show Affiliations »
Abstract
Entities: Chemical Disease
Mesh： See more » AdalimumabAntibodies/bloodAntibodies, Monoclonal/bloodAntibodies, Monoclonal/immunologyAntibodies, Monoclonal/therapeutic useAntibodies, Monoclonal, HumanizedAntirheumatic Agents/bloodAntirheumatic Agents/immunologyAntirheumatic Agents/therapeutic useArthritis, Juvenile/drug therapyChildHumansTumor Necrosis Factor-alpha/antagonists & inhibitors
Substances： See more » AntibodiesAntibodies, MonoclonalAntibodies, Monoclonal, HumanizedAntirheumatic AgentsTumor Necrosis Factor-alphaAdalimumab
Year: 2008 PMID： 19065700
Source DB: PubMed Journal: N Engl J Med ISSN： 0028-4793 Impact factor: 91.245